$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Allantoin gel product overview and sales trends
2026-02-01 22:25:32
Check Details
Detailed introduction to the interactions between Vanzacato/Tizacaftor/Deuterated Ivacaftor composite tablets and other drugs
2026-02-01 22:25:32
Check Details
Overview of the official instructions for use of Fidanaco-Ella Parvowitz Gene Therapy
2026-02-01 22:25:32
Check Details
How long is the usual course of treatment with upadatinib?
2026-02-01 22:25:32
Check Details
Should I take nintedanib before or after meals?
2026-02-01 22:25:32
Check Details
Can bimetinib (bemetinib) and trametinib be used together?
2026-02-01 22:25:32
Check Details
What is the usage and dosage of teclistamab?
2026-02-01 22:25:32
Check Details
What is the difference between Quizartinib and Giritinib?
2026-02-01 22:25:32
Check Details
How long is the treatment period for bedaquiline? How long does it take to take effect?
2026-02-01 22:25:32
Check Details
What is the difference between dasatinib and imatinib? How do treatment effects differ from side effects?
2026-02-01 22:25:32
Check Details
What is the mechanism of action of Anamorelin? Is it a receptor agonist?
2026-02-01 22:25:32
Check Details
What is the difference between Aleminib and Baricitinib? Analysis of functions and indications
2026-02-01 22:25:32
Check Details
1
2
...
1461
1462
1463
1464
1465
1466
1467
...
10212
10213
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Venetoclax (Venetoclax): Balancing Precision with Risk Management in Hematologic Malignancies
2
Global Breakthrough: Pralsetinib - Precision Medicine for RET Mutation-Driven Cancers
3
A Comprehensive Guide to Benralizumab Adverse Reactions: Prevention and Management
4
Lemborexant: A Dual Orexin Receptor Antagonist Revolutionizing Insomnia Treatment
5
Breztri Aerosphere Approved by US FDA for Maintenance Treatment of Asthma in Patients Aged 12 Years and Older
6
Datopotamab Deruxtecan as First-Line Treatment for Advanced Triple-Negative Breast Cancer: Full Interpretation of the Phase III TROPION-Breast02 Trial
7
Elacestrant: Precision Therapy for ESR1-Mutant Resistant HR+/HER2- Advanced Breast Cancer
8
Vibegron 2026 Research Updates: New Evidence for Overactive Bladder Treatment
9
Elafibranor for Cholestatic Liver Diseases: Efficacy Maintenance and Drug Resistance Analysis
10
Benzgalantamine (Zunveyl) for Alzheimer's Disease: Efficacy and Optimal Treatment Stages
11
Loargys(Pegzilarginase-nbln) Complete Medication Guide: Pre-Treatment Assessment, Monitoring and Home Administration
12
Plerixafor Complete Side Effect Guide: Adverse Reaction Classification and Professional Management